HLCS, VRX, BVF - Pharmaceutical Giants Merge and Grow - source PicksThatMove.com

June 22, 2010 - PRLog -- Calgary, Alberta –PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation.  These companies have interesting business models and they have to execute on the business development level to bring value to shareholders.  Some of our past picks had soared over 200%.  To view some of our profiled stocks, please visit our website at www.picksthatmove.com

Helicos Biosciences Corp , is a life sciences company focused on genetic analysis technologies for the research, drug discovery and clinical diagnostics markets.  The stock is trading at $0.485 for a (0.01, 2.1%) gain.  HLCS has a unique proprietary technology called True Single Molecule Sequencing which enables rapid analysis of large quantities of genetic material by directly sequencing single molecules of DNA.

Valeant Pharmaceuticals  opened this morning at $47.12 and has climbed an impressive (+3.25, 7%) as they are trading at $50.15. VRX operates as a multinational speciality pharmaceutical company where they develop and manufacture a range of pharmaceutical products.  Yesterday they announced that they are going to enter a definitive merger agreement that is going to be acquired by Biovail Corporation.

Biovail Corporation , is a speciality pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. BVF has been engaged in the formulation, clinical testing, registration and manufacturing of pharmaceutical products.  Yesterday they announced that they have agreed to merge with Valeant Pharmaceuticals International in a deal worth US $3.3 billion.

About PicksThatMove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned here in and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.